Guardant Health, Inc..
GH.US | Research and experimental development on natural sciences and engineering
Guardant Health, Inc. is a precision oncology company focused on developing non-invasive cancer tests. Their primary business involves providing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in blood samples to detect cancer early, identify actionable mutations, and monitor treatmen...Show More
Better Health for All
10
Guardant Health's core business is developing non-invasive cancer tests, with its entire portfolio devoted to health improvement through cancer screening, therapy selection, and recurrence monitoring. The company has no revenue from products with established negative health outcomes.
1
Its Shield test has a false negative rate of 1 in 10 for precancer and a false positive rate.
2
The Shield test is covered by Medicare for over 45 million beneficiaries, resulting in $0 out-of-pocket costs for Medicare Part-B patients, though pricing for other plans is not disclosed.
3
The company has over 500 peer-reviewed publications, with approximately 100 annually over the past two years, demonstrating significant investment in R&D.
4
Its products, like the Shield test, are intended for preventative screening.
5
The company educates the public by debunking myths about blood-based cancer screening.
6
Guardant Health conducts clinical trials, including Phase 3 SERENA-6, Alliance N0147, SWOG S1416, and TRITON2 trials, but there is no information on ethical conduct or diversity in these trials.
7
Fair Money & Economic Opportunity
0
No evidence available to assess Guardant Health, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
-20
Employee satisfaction regarding fair pay is reported at 45%.
1
The company's compensation is ranked in the bottom 40% of similar-sized companies, while its perks and benefits are in the top 40%.
2
All employees surveyed reported satisfaction with annual bonuses (100%), and 68% were satisfied with benefits.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess Guardant Health, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-50
Guardant Health has a formal whistleblower policy that allows for anonymous reporting, maintains confidentiality, and prohibits retaliation.
1
The company also has a Global Anti-Corruption Policy that prohibits bribery, improper payments, and facilitation payments to foreign officials and commercial parties.
2
This policy outlines specific rules for gifts, hospitality, entertainment, third-party dealings, and political contributions, and requires periodic compliance certifications from employees.
3
It also emphasizes compliance with the Foreign Corrupt Practices Act (FCPA) and the importance of accurate books, records, and internal controls.
4
However, there is no evidence of specific training frequency, effectiveness metrics, or third-party monitoring for the anti-corruption policy, nor is there evidence regarding the number of reports filed or trust in confidentiality for the whistleblower policy.
Kind to Animals
20
Guardant Health states that its clinical and nonclinical studies do not involve the use of animals, indicating that non-animal platforms replace every in vivo test.
1
The company's policy prohibits animal testing except where legally required, and any such use would adhere to best practice standards.
2
Currently, zero animals are used in testing.
3
The company engages in lobbying efforts to broaden access to testing and support legislation mandating coverage for biomarker testing.
4
No War, No Weapons
0
The provided articles do not contain specific, quantifiable evidence for Guardant Health, Inc. related to any of the 'No War, No Weapons' KPIs. While one article mentions the company's Shield blood test is covered by TRICARE for active-duty service members and their families, this is a healthcare service and does not constitute involvement in arms manufacturing, military contracts, or dual-use technology as defined by the rubric.
1
Planet-Friendly Business
-40
Guardant Health reported total Scope 1 and 2 greenhouse gas emissions of 4,222 tCO₂e for 2023.
1
While Scope 3 emissions data was not provided,
2
the reported Scope 1 and 2 emissions are significantly low. The company has committed to establishing GHG reduction targets aligned with the Science Based Targets Initiative (SBTi),
3
but these targets are currently awaiting validation. Guardant Health has set a near-zero emissions target for Scope 1 and 2 by 2025 and a 30% emissions reduction target for Scope 1 and 2 by 2030.
4
The company reported no environmental violations or penalties.
5
Respect for Cultures & Communities
0
No evidence available to assess Guardant Health, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-20
Guardant Health experienced a data breach affecting 9,309 individuals between September 2023 and February 2024, where an unidentified third party downloaded a file containing patient data including names, age, medical record numbers, and treatment information.
1
In response, the company provided further employee training.
2
The company's privacy policy, last updated May 9, 2025, states that personal data is retained only as long as necessary to fulfill purposes, including legal obligations, and that service providers receive only the personal data required for contracted services.
3
Guardant Health offers users the ability to correct personal data through portals and opt-out of promotional emails, and users have rights such as to know, delete, and opt-out of selling/sharing data.
4
The company has appointed a Security Officer, Privacy Officer, and Data Protection Officer.
5
It states compliance with various regulations including HIPAA, GDPR, UK GDPR, Swiss FADP, Japan's APPI, Singapore PDPA, and CCPA.
6
Guardant Health holds CLIA, CAP, and several state health department licenses for its facilities.
7
The company's Supplier Code of Conduct, dated September 17, 2024, requires suppliers handling Guardant Health Data to implement robust physical, organizational, and technical measures, maintain data security protocols aligned with industry best practices, and comply with applicable regulatory requirements.
8
The privacy policy also mentions password protection as a security measure.
9
Zero Waste & Sustainable Products
-50
The company reported no environmental violations or penalties in its 2023 ESG report and 2025 Corporate Responsibility Report.
1
Hazardous and medical waste generated increased from approximately 166,000 lbs in 2023 to 192,000 lbs in 2024.
2
The Supplier Code of Conduct outlines expectations for suppliers to manage waste responsibly, but no specific requirements or performance metrics for suppliers are provided.
3